analyzeportfolio
Nasdaq · Financials

Core Scientific, Inc./tx (CORZ)

As-reported financials and SEC filings for Core Scientific, Inc./tx. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About Core Scientific, Inc./tx

Core Scientific, Inc. designs, builds, and operates large-scale data centers that provide high-density colocation services and digital asset mining. The company serves customers including hyperscale cloud providers, AI and high-performance computing operators, and large enterprises by offering secure space, reliable power, and cooling for IT equipment. Core Scientific owns or leases ten data centers across seven U.S. states with a focus on supporting power-intensive computing workloads.

Snapshot

Revenue
$319.0M
Revenue growth (YoY)
-37.5%
Net income
$-288.6M
Diluted EPS
$-0.88
Gross margin
11.9%
Operating margin
-77.0%
Net margin
-90.5%
FCF margin
-141.3%
ROE
net income / fiscal-year-end equity
P/E
trailing when available, otherwise FY EPS
Market cap
$5.24B
Long-term debt / equity
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Core Scientific, Inc./tx

  • Revenue fell 37.5% to $319M in FY2025, slower than the 1.6% the year before.
  • Operating margin is now a 77.0% loss in FY2025, from 24.2% in FY2021.
  • Most recent quarter Q2 FY2026: revenue $164M, up 108.8% from Q2 FY2025.
  • Free cash flow was negative $451M in FY2025.
  • Net loss narrowed to $289M in FY2025, from $1.4B in FY2024.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Core Scientific, Inc./tx’s fundamentals sit among the 425 Financials companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Gross margin11.9%
14th percentile of 51
Operating margin-77.0%
6th percentile of 146
Net margin-90.5%
1st percentile of 377
FCF margin-141.3%
1st percentile of 272
Revenue growth (YoY)-37.5%
3rd percentile of 420
Short interest5.14d
65th percentile of 420

Core Scientific, Inc./tx’s net margin of -90.5% ranks in the 1st percentile of the 377 Financials companies reporting it. Core Scientific, Inc./tx’s FCF margin of -141.3% ranks in the 1st percentile of the 272 Financials companies reporting it. Core Scientific, Inc./tx’s revenue growth of -37.5% ranks in the 3rd percentile of the 420 Financials companies reporting it.

2 reported insider purchases (code P) totaling $244,352 in the last 90 days, against 23 sales totaling $2.8M. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 3 of the superinvestors we track (plus 6 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).

Conviction investors
3
+6 quant / multi-strat
Initiated / added
6
2 new, 4 added
Reduced / exited
4
3 trimmed, 1 exited
Combined position
$652.0M
reported long value
InvestorAs ofPosition valueSharesChange
Two Sigma InvestmentsquantQ2 2026$263.0M10.3MAdded
Citadel AdvisorsquantQ2 2026$103.4M4.0MReduced
Millennium ManagementquantQ2 2026$89.8M3.5MAdded
D. E. ShawquantQ2 2026$85.6M3.3MAdded
Renaissance TechnologiesquantQ2 2026$84.9M3.3MAdded
Tiger Global ManagementQ2 2026$20.9M817.0KNew
AQR Capital ManagementquantQ2 2026$2.1M82.7KReduced
Third PointQ2 2026$1.4M54.0KNew
Soros Fund ManagementQ2 2026$899,41235.1KReduced

No longer held by: Point72 Asset Management (as of Q2 2026)

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4. Multiple insiders have bought recently (a cluster buy).

Buys (90d)
2
2 insiders
Bought (90d)
$244K
code P value
Sells (90d)
23
$2.8M
Reported activity
Cluster buy
≥2 insiders buying
Trade dateInsiderTypeSharesPriceValue
2026-08-24
filed 2026-08-26
DUCHENE TODD MSee remarksSell10.0K$17.45$174K
2026-08-20
filed 2026-08-24
CRAIN ELIZABETHDirectorBuy6.0K$18.33$110K
2026-08-18
filed 2026-08-20
Weiss Eric StantonDirectorBuy7.0K$19.19$134K
2026-08-17
filed 2026-08-19
DUCHENE TODD MSee remarksSell10.0K$20.10$201K
2026-08-10
filed 2026-08-12
DUCHENE TODD MSee remarksSell9.0K$19.90$179K
2026-08-10
filed 2026-08-12
DUCHENE TODD MSee remarksSell1.0K$20.65$21K
2026-08-03
filed 2026-08-05
DUCHENE TODD MSee remarksSell7.5K$22.62$170K
2026-08-03
filed 2026-08-05
DUCHENE TODD MSee remarksSell1.5K$21.55$32K
2026-08-03
filed 2026-08-05
DUCHENE TODD MSee remarksSell1.0K$20.39$20K
2026-07-27
filed 2026-07-29
DUCHENE TODD MSee remarksSell8.3K$20.75$172K
2026-07-27
filed 2026-07-29
DUCHENE TODD MSee remarksSell1.6K$21.89$35K
2026-07-27
filed 2026-07-29
DUCHENE TODD MSee remarksSell100$22.49$2K

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
63.4M
settled 2026-08-14
Change vs prior
+0.5%
vs previous settlement
Days to cover
5.14
at avg daily volume
Avg daily volume
12.3M
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-1463.4M+0.5%5.14
2026-07-3163.1M-0.3%4.57
2026-07-1563.4M-8.3%5.74
2026-06-3069.1M-7.5%5.58
2026-06-1574.7M+4.0%6.20
2026-05-2971.9M+12.2%5.42
2026-05-1564.1M-2.3%3.56
2026-04-3065.6M+9.0%4.39

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$319.0M$510.7M$502.4M$640.3M$544.5M
Gross profit$37.9M$121.1M$123.5M$8.4M$238.9M
Operating income$-245.6M$-142.1M$9.0M$-2.11B$131.5M
Net income$-288.6M$-1.44B$-246.5M$-2.15B$47.3M
Diluted EPS$-0.88$-4.87$-0.65$-6.30$0.20

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

 FY2025FY2024FY2023FY2022FY2021
Cash and equivalents$311.4M$836.2M$50.4M$15.9M$117.9M
Current assets$895.5M$904.0M$97.0M$85.1M$756.6M
Total assets$2.35B$1.48B$712.2M$807.7M$2.44B
Current liabilities$781.4M$134.6M$488.4M$186.8M$320.3M
Long-term debt$1.06B
Total liabilities$3.31B$2.42B$1.31B$1.22B$1.05B
Total equity$-962.7M$-943.0M$-596.9M$-409.3M$1.34B

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$278.3M$42.9M$65.1M$205.2M$-56.7M
Capital expenditure$729.0M$95.0M$16.2M$384.0M$0
Free cash flow$-450.8M$-52.1M$49.0M$-178.8M$-56.7M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$164.2M108.8%$-1.16B$-3.32
Q1 FY2026$115.2M44.9%$-347.2M$-1.06
Q4 FY2025$79.8M-16.0%$216.0M$0.67
Q3 FY2025$81.1M-14.9%$-144.0M$-0.45
Q2 FY2025$78.6M-44.3%$-936.8M
Q1 FY2025$79.5M-55.6%$576.3M$1.24
Q4 FY2024$94.9M-33.1%$-291.1M$-1.10
Q3 FY2024$95.4M-15.5%$-455.3M$-1.17

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNasdaq
SectorFinancials
SIC industryFinance Services
Latest annual periodFY2025 (ended December 31, 2025)
Latest reported quarterQ2 FY2026 (ended June 30, 2026)
Oldest indexed filing2021
SEC CIK1839341

Selected SEC filings

10-Q2026-07-28
View on EDGAR →
10-Q2026-05-06
View on EDGAR →
8-K2026-08-27
View on EDGAR →
8-K2026-08-14
View on EDGAR →
8-K2026-07-29
View on EDGAR →
8-K2026-07-28
View on EDGAR →

Largest Financials peers

All Financials companies →

Monitor CORZ

Get an alert when Core Scientific, Inc./tx files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor CORZ free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.